管理前列腺癌患者与恩扎鲁胺的药物相互作用:一个播客
Alicia K Morgans1, Brooke Looney2, Jesse Mack3
1Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Dana 09-930, Boston, MA, 02215, USA. aliciak_morgans@dfci.harvard.edu.
Drug safety
|September 16, 2025
概括
用于治疗前列腺癌的恩扎胺可以与其他药物相互作用. 了解这些药物相互作用 (DDI) 和调整剂量可以帮助管理风险并确保有效治疗.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 药物相互作用 药物相互作用
背景情况:
- 恩扎胺是一种口服的雄激素受体信号抑制剂,用于前列腺癌治疗.
- 老年患者经常有并发症,需要同时服用药物.
- 恩扎胺是CYP2C9/CYP2C19的中度诱导剂,也是CYP3A4的强诱导剂,具有DDI风险.
研究的目的:
- 描述恩扎胺的药理动力学和DDI潜力.
- 用病例来说明使用恩扎拉胺相关DDI的管理策略.
主要方法:
- 讨论假设的患者病例,涉及同期使用恩扎胺.
- 对恩扎胺剂量,药理动力学和CYP酶相互作用的审查.
主要成果:
- 恩扎胺对CYP酶的诱导可能会导致降低疗效或增加与同时使用药物的不良事件.
- 管理策略的重点是识别相互作用的药物,剂量调整和替代.
结论:
- 大多数恩扎胺DDI在适当的知识下是可以管理的.
- 有效的管理确保了前列腺癌和并发症患者的治疗有效性和安全性.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
257
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
257
Pharmacokinetics: Drug–Drug Interactions
364
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
364
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
204
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
204
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
511
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
511
Urinary Tract Calculi III: Medical Management
196
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
196
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
169
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169


